REYON Trademark

Trademark Overview


On Wednesday, September 9, 2020, a trademark application was filed for REYON with the United States Patent and Trademark Office. The USPTO has given the REYON trademark a serial number of 79298272. The federal status of this trademark filing is REGISTERED as of Tuesday, November 30, 2021. This trademark is owned by REYON PHARMACEUTICAL CO.,LTD.. The REYON trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical agents affecting metabolism; vitamin and mineral preparations for medical use; crude medicines, namely, medicines for the treatment and prevention of atopic skin disease, obesity, digestive disorders, and immune system related diseases and disorders; anti-inflammatory and antipyretic preparations; cardiovascular pharmaceutical preparations; dietetic food supplements; food for babies; preparations of microorganisms for medical or veterinary use; medical and surgical plasters; pharmaceutical and veterinary preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, and immune system related diseases and disorders; pharmaceutical and veterinary preparations for treating allergic rhinitis and asthma; pharmaceutical and veterinary preparations for ocular and intraocul...
reyon

General Information


Serial Number79298272
Word MarkREYON
Filing DateWednesday, September 9, 2020
Status700 - REGISTERED
Status DateTuesday, November 30, 2021
Registration Number6571380
Registration DateTuesday, November 30, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 14, 2021

Trademark Statements


Goods and ServicesPharmaceutical agents affecting metabolism; vitamin and mineral preparations for medical use; crude medicines, namely, medicines for the treatment and prevention of atopic skin disease, obesity, digestive disorders, and immune system related diseases and disorders; anti-inflammatory and antipyretic preparations; cardiovascular pharmaceutical preparations; dietetic food supplements; food for babies; preparations of microorganisms for medical or veterinary use; medical and surgical plasters; pharmaceutical and veterinary preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, and immune system related diseases and disorders; pharmaceutical and veterinary preparations for treating allergic rhinitis and asthma; pharmaceutical and veterinary preparations for ocular and intraocular surgery; pharmaceutical and veterinary preparations acting on the central nervous system; pharmaceutical and veterinary preparations for the prevention of osteoporosis; pharmaceutical and veterinary preparations for use in urology; pharmaceutical and veterinary preparations, namely, drug delivery systems comprising polymer-based oral tablets for the continuous release of therapeutic agents; pharmaceutical and veterinary preparations for use in the anesthesia; pharmaceutical and veterinary preparations for diagnostic purposes; pharmaceutical and veterinary preparations for the peripheral nervous system; pharmaceutical and veterinary preparations for digestive organs; pharmaceutical and veterinary preparations for anti-fungal treatment; nutraceutical preparations for therapeutic or medical purposes; antibiotics; anti-cancer preparations; pharmaceutical preparations for respiratory organs; all aforementioned goods sold only to hospitals or other healthcare institutions and to pharmaceutical companies

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, November 20, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameREYON PHARMACEUTICAL CO.,LTD.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressKR

Party NameREYON PHARMACEUTICAL CO.,LTD.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressKR

Party NameREYON PHARMACEUTICAL CO.,LTD.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressKR

Trademark Events


Event DateEvent Description
Sunday, June 12, 2022FINAL DECISION TRANSACTION PROCESSED BY IB
Saturday, May 21, 2022FINAL DISPOSITION NOTICE SENT TO IB
Friday, May 20, 2022FINAL DISPOSITION PROCESSED
Monday, February 28, 2022FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, November 30, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, September 14, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 14, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 14, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 14, 2021PUBLISHED FOR OPPOSITION
Thursday, August 26, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, August 26, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, August 26, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, August 11, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 3, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 3, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 3, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, March 1, 2021REFUSAL PROCESSED BY IB
Friday, February 5, 2021NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, February 5, 2021REFUSAL PROCESSED BY MPU
Friday, January 22, 2021NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, January 21, 2021NON-FINAL ACTION WRITTEN
Tuesday, January 19, 2021ASSIGNED TO EXAMINER
Tuesday, November 24, 2020APPLICATION FILING RECEIPT MAILED
Friday, November 20, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, November 19, 2020SN ASSIGNED FOR SECT 66A APPL FROM IB